Baptist Health partners with ALA in ‘Saved By the Scan’ campaign

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Baptist Health South Florida and the American Lung Association have partnered to raise awareness for lung cancer screenings through “Saved by the Scan,” a public service advertising campaign aimed at educating Americans about the low-dose CT scan available to those at high risk for the disease.

The low-dose CT scan can detect lung cancer in its early stages, before symptoms arise, when the disease is more curable.

In 2014, Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Juan Batlle, chief of thoracic imaging at Baptist Health, launched Baptist Health’s lung cancer screening program with the support of Dennis Bookshester.

Screening is available throughout Baptist Health. For eligible patients, Medicare and most private insurance companies cover the screening cost.

The South Florida “Saved by the Scan” comprehensive public awareness campaign includes a video public service announcement, digital and print advertisements, and social media.

Table of Contents

YOU MAY BE INTERESTED IN

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login